We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Arrevus Inc today announced receipt of a $1.5 million Fast-Track grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)